论文部分内容阅读
BACKGROUND:Hepatocellular carcinoma(HCC)which is always refractory to most chemotherapeutic agents may result in poor survival of patients with advanced HCC. Oncolytic adenovirus is a new form for cancer gene therapy via its ability to replicate and kill